lactic acid has been researched along with lutetium lu 177 dotatate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, G; Bandopadhyaya, G; Ghosh, S; Malhotra, A; Maulik, SK; Shukla, J | 1 |
| Arora, G; Bandopadhyaya, G; Dubey, P; Ghosh, S; Shukla, J | 1 |
2 other study(ies) available for lactic acid and lutetium lu 177 dotatate
| Article | Year |
|---|---|
PLGA nanoparticles for peptide receptor radionuclide therapy of neuroendocrine tumors: a novel approach towards reduction of renal radiation dose.
Topics: Animals; Kidney; Lactic Acid; Nanoparticles; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Radiation Dosage; Rats; Rats, Wistar; Receptors, Somatostatin | 2012 |
Evaluation of cytotoxic and tumor targeting capability of (177)Lu-DOTATATE-nanoparticles: a trailblazing strategy in peptide receptor radionuclide therapy.
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Chorionic Gonadotropin, beta Subunit, Human; Feasibility Studies; Glioblastoma; Humans; Lactic Acid; Male; Molecular Targeted Therapy; Nanoparticles; Octreotide; Organometallic Compounds; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Receptors, Somatostatin | 2016 |